Our use of cookies

We use necessary cookies to make our site work. We’d also like to set optional analytics cookies to help us improve it. We won’t set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences.

For more detailed information about the cookies we use, see Privacy & Cookies

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone.


Back to all News

Imperial Brands responds to FDA announcement

We welcome the US Food and Drug Administration’s (FDA) moves to prevent youth access to tobacco and vapour products.

We share the same concerns and objectives as the FDA: the use by minors of these products is completely unacceptable. Vapour products are for adult smokers and their sale to anyone underage should be prevented. However, we also recognise the challenge faced by the FDA in balancing concerns regarding youth appeal and access, given the positive public health potential of vapour products.   

We believe that through our blu product range we offer adult smokers a significantly better alternative than combustible cigarettes and consistently reinforce this message, while at the same time working actively against youth access to, and usage of, our products.  

On the FDA’s specific actions, we welcome its commitment to standards for effective age verification for all online sales of vapour products; a technology which we already use on blu.com.  

We recognise the FDA’s concern over age verification at brick-and-mortar retail outlets and will consider further appropriate actions. The availability of quality vaping products like blu in outlets where tobacco products are sold is vital to help adults transition away from combustible tobacco.   

We are developing a connected version of myblu with device locking technology and are greatly encouraged by Commissioner Gottlieb’s comment on a process to accelerate development and review of vapour products with child protection features.  

We also note today the FDA’s proposals regarding menthol cigarettes and flavoured cigars, which would need to be supported by the relevant science and other evidence. Such proposals are likely to require a multi-year process, in which we will be fully engaged.